NCT02810847

Brief Summary

Around one child in fifty has a lazy eye (termed amblyopia) where the eye is structurally normal but the vision fails to develop correctly. Around half of these children also have a squint (strabismus) where each eye has a different direction of gaze. This condition is the commonest cause of visual impairment in one eye in children. This is a randomised control trial of wearing glasses alone (which will result in some visual improvement, termed refractive adaptation) and wearing glasses combined with using I-BiT Plus. The hypothesis is that using I-BiT Plus will result in an improved visual outcome.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 23, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

June 23, 2016

Status Verified

June 1, 2016

Enrollment Period

1.5 years

First QC Date

April 26, 2016

Last Update Submit

June 20, 2016

Conditions

Keywords

Amblyopiastrabismusvirtual realitycomputer games

Outcome Measures

Primary Outcomes (1)

  • The change of visual acuity from baseline to week six post randomisation visit between the two arms in each group.

    6 weeks

Secondary Outcomes (17)

  • Successful delivery and installation of equipment to patients' homes, and any reasons for failure

    10 weeks

  • The ability of the patients to use the equipment in their home (unsupervised) setting and any reasons why not. Ocular alignment Stereoacuity Proportion of patients completing course

    10 weeks

  • The time taken by the patients to use the equipment in their home (unsupervised) setting.

    10 weeks

  • The robustness of the equipment by measuring failure / breakage rate.

    10 weeks

  • Completeness of outcome measures will be assessed via the frequency of missing data.

    10 weeks

  • +12 more secondary outcomes

Study Arms (2)

I-BiT Plus

EXPERIMENTAL

6 weeks of I-Bit treatment plus (at least 30 mins/day, 6 days/week)

Device: I-Bit plus

Control

NO INTERVENTION

Refractive adaption or observation

Interventions

The study will treat amblyopia (lazy eye) using 3-D computer technology and active shutter glasses. Computer games and DVD's are viewed through the active shutter glasses and are specially prepared to preferentially stimulate the lazy eye; the child can only play the game accurately if they are using their lazy eye.

I-BiT Plus

Eligibility Criteria

Age42 Months - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The child must be aged between 3 years 6 months and 9 years 11 months (upper limit is one day before their 10th birthday on day of consent.)
  • Visual acuity difference of at least 0.3 log units, with the amblyopic eye being 0.3 logMAR or worse.
  • Must have undergone a minimum of 12 weeks refractive adaptation.
  • Those in group one must not have had patching or penalisation at all previously but the other two groups' participants may have had previous occlusion.
  • Must not have had previous strabismus surgery (for groups one and two, and for group three, they must start the treatment within 4 weeks of having surgery.
  • Must be able to use the I-BiT plus system.

You may not qualify if:

  • Stimulus deprivation amblyopia.
  • Other ocular or neurological disease affecting the visual system (including Down's syndrome, developmental delay,Craniofacial syndrome,Foetal Alcohol Syndrome, and cerebral palsy among other conditions).
  • Photosensitive epilepsy.
  • Parent, guardian or child not prepared to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Brown R, Blanchfield P, Fakis A, McGraw P, Foss AJE; I-BiT Study Group. Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial. Trials. 2019 Jul 16;20(1):437. doi: 10.1186/s13063-019-3523-0.

MeSH Terms

Conditions

AmblyopiaStrabismus

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve Diseases

Study Officials

  • Alexander JE Foss, DM FRCOphth MRCP

    Nottingham University Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2016

First Posted

June 23, 2016

Study Start

June 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

June 23, 2016

Record last verified: 2016-06